Balance Sheet StrengthA strong balance sheet with low leverage indicates financial stability and the ability to withstand economic fluctuations, supporting long-term growth.

ProfitabilityHigh profitability margins suggest effective cost management and pricing power, which can sustain competitive advantage and shareholder returns over time.

Cash GenerationStrong cash generation relative to net income ensures liquidity and the ability to reinvest in growth opportunities or return capital to shareholders.

Bears Say

Negative Revenue GrowthDeclining revenue growth poses a challenge to sustaining market position and could impact future profitability if not addressed through strategic initiatives.

Cash Flow VolatilityVolatility in cash flow generation can affect the company's ability to fund operations and growth, potentially leading to financial strain during downturns.

Revenue Growth ChallengeStagnant or declining revenue growth can hinder the company's ability to expand its market presence and invest in new technologies or products, affecting long-term competitiveness.

Human Metabolome Technologies, Inc. News

Human Metabolome Technologies Reports Profit Decline but Maintains Strong Equity Base

An update from Human Metabolome Technologies, Inc. ( ($JP:6090) ) is now available. Human Metabolome Technologies, Inc., a...

4d ago

6090

Human Metabolome Technologies Posts Profit Decline but Maintains Strong Equity Base

The latest announcement is out from Human Metabolome Technologies, Inc. ( ($JP:6090) ). Human Metabolome Technologies, Inc., listed...

4d ago

6090

Human Metabolome Technologies Reports Financial Decline in Q3 2025

The latest update is out from Human Metabolome Technologies, Inc. ( ($JP:6090) ). Human Metabolome Technologies, Inc. reported...

3M ago

6090

Human Metabolome Technologies Reports Strong Fiscal Year Performance

The latest update is out from Human Metabolome Technologies, Inc. ( ($JP:6090) ). Human Metabolome Technologies, Inc. reported...

6M ago

6090

Human Metabolome Technologies Reports Strong Financial Growth in Q1 2025

The latest announcement is out from Human Metabolome Technologies, Inc. ( ($JP:6090) ). Human Metabolome Technologies, Inc. reported...

9M ago

6090

Human Metabolome Technologies Reports Strong Quarterly Financial Performance

Human Metabolome Technologies, Inc. ( ($JP:6090) ) has provided an update. Human Metabolome Technologies, Inc. reported a significant...

9M ago

6090

Human Metabolome Technologies Reports Robust Quarterly Growth

Human Metabolome Technologies, Inc. ( ($JP:6090) ) just unveiled an update. Human Metabolome Technologies, Inc. reported an 8.1%...

1y ago

6090

Human Metabolome Technologies Financial Update

Human Metabolome Technologies, Inc. (JP:6090) has released an update. Human Metabolome Technologies, Inc. reports a slight increase in...

2y ago

6090

6090 FAQ

What was Human Metabolome Technologies, Inc.’s price range in the past 12 months?

Human Metabolome Technologies, Inc. lowest stock price was ¥590.00 and its highest was ¥869.00 in the past 12 months.

What is Human Metabolome Technologies, Inc.’s market cap?

Human Metabolome Technologies, Inc.’s market cap is ¥4.21B.

When is Human Metabolome Technologies, Inc.’s upcoming earnings report date?

Human Metabolome Technologies, Inc.’s upcoming earnings report date is Feb 18, 2026 which is in 2 days.

How were Human Metabolome Technologies, Inc.’s earnings last quarter?

Human Metabolome Technologies, Inc. released its earnings results on Nov 12, 2025. The company reported -¥17.1 earnings per share for the quarter, missing the consensus estimate of N/A by -¥17.1.

Is Human Metabolome Technologies, Inc. overvalued?

According to Wall Street analysts Human Metabolome Technologies, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Human Metabolome Technologies, Inc. pay dividends?

Human Metabolome Technologies, Inc. pays a Annually dividend of ¥15 which represents an annual dividend yield of 2.35%. See more information on Human Metabolome Technologies, Inc. dividends here

What is Human Metabolome Technologies, Inc.’s EPS estimate?

Human Metabolome Technologies, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Human Metabolome Technologies, Inc. have?

Human Metabolome Technologies, Inc. has 5,919,797 shares outstanding.

What happened to Human Metabolome Technologies, Inc.’s price movement after its last earnings report?

Human Metabolome Technologies, Inc. reported an EPS of -¥17.1 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.019%.

Which hedge fund is a major shareholder of Human Metabolome Technologies, Inc.?

Currently, no hedge funds are holding shares in JP:6090

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Human Metabolome Technologies, Inc.

Human Metabolome Technologies, Inc. (6090) is a biotechnology company specializing in the analysis of human metabolites to advance the understanding of human health and disease. The company operates primarily in the life sciences sector, offering a range of services that include metabolomics research, biomarker discovery, and diagnostic development. Its core products include advanced analytical platforms and proprietary software for metabolomic data analysis, catering to pharmaceutical companies, academic institutions, and healthcare providers.